Clarix Imaging announced that it secured $10 million in funding to support its volumetric specimen imaging system.
The state-of-the-art, point-of-care 3D imaging platform enables the real-time assessment of surgical specimens in the operating room. Its uses include oncology, with the potential to benefit the 300,000 patients diagnosed with breast cancer in the U.S. each year.
Clarix said in a news release that it’s seen a surge in demand for its platform since commercialization. It plans to use the funds from Kineo Finance, plus an upcoming equity financing round, to foster growth and development.
The Clarix platform utilizes unique image reconstruction technology for imaging at high, isotropic resolution with significantly reduced scan time. It enabled Clarix to create a portable system to meet space and time demands within the operating room workflow. This way, surgeons receive rapid verification of the excision of the correct tissue.
Clarix says its expertise in volumetric imaging and library of 3D breast cancer images could also unlock future applications. The company said its know-how enables advancements in AI that could enhance patient care.
“This pivotal partnership with Kineo Finance will help us increase production and provide innovative financing solutions to make our groundbreaking technology accessible to healthcare facilities in the United States and, eventually, in international markets,” said Clarix Imaging CEO and co-founder, Xiao Han. “As we execute our ambitious growth priorities, we are thrilled to be guided by kineo finance’s deep expertise in the global medical technology industry.”